Breadcrumb

IDIGH  |  Infectious Diseases and Immunity in Global Health Program

IDIGH Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

CTN study tests new drug for the first time in people living with HIV

Postdoc Léna Royston aims to understand how cytomegalovirus infection can increase inflammation and cause health issues

Fall 2021 CIHR competition results

RI-MUHC teams received $9.5 million in project funding

Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity

Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency...

A clear picture of the cost and efficacy of COVID-19 outpatient treatments

In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...

Three RI-MUHC research projects funded in special CIHR calls

Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence

Can inhaled corticosteroids alleviate early symptoms of COVID-19?

Results from the CONTAIN study conducted at the RI-MUHC reveal that ciclesonide is no better than placebo

RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response

Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...

The 2021 RI-MUHC Annual Report is online!

An invitation from Dr. Rhian Touyz

RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children

Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available

Explore news and events at the RI-MUHC